ContractAmarin Corp Plc\uk • November 20th, 2015 • Pharmaceutical preparations • New York
THE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE ‘‘SECURITIES ACT’’), AND, ACCORDINGLY, THIS NOTE AND ANY AMERICAN DEPOSITARY SHARES ISSUABLE UPON EXCHANGE OF THIS NOTE (AND ANY BENEFICIAL INTEREST HEREIN OR THEREIN) MAY NOT BE OFFERED, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:
SUBSCRIPTION AGREEMENTSubscription Agreement • November 20th, 2015 • Amarin Corp Plc\uk • Pharmaceutical preparations
BAKER BROTHERS LIFE SCIENCES, L.P. (the “Holder”) hereby enters into this Subscription Agreement (this “Agreement”) with Amarin Corporation plc, a public limited company incorporated under the laws of England and Wales (the “Company”), on November 19, 2015, in order to subscribe for the purchase (the “Purchase”) of a November 2015 3.50% Exchangeable Senior Note due 2032 (the “Note”), substantially in the form of Exhibit B hereto, in consideration of the purchase price specified below.
